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Abstract
Background: Endothelial tight and adherens junctions control a variety of physiological processes like adhesion,
paracellular transport of solutes or trafficking of activated leukocytes. Formation and maintenance of endothelial
junctions largely depend on the microenvironment of the specific vascular bed and on interactions of the
endothelium with adjacent cell types. Consequently, primary cultures of endothelial cells often lose their specific
junctional pattern and fail to establish tight monolayer in vitro. This is also true for endothelial cells isolated from
the vein of human umbilical cords (HUVEC) which are widely used as model for endothelial cell-related studies.
Results: We here compared the effect of cyclic 3’-5’-adenosine monophosphate (cAMP) and its derivates on
formation and stabilization of tight junctions and on alterations in paracellular permeability in HUVEC. We
demonstrated by light and confocal laser microscopy that for shorter time periods the sodium salt of 8-
bromoadenosine-cAMP (8-Br-cAMP/Na) and for longer incubation periods 8-(4-chlorophenylthio)-cAMP (pCPT-
cAMP) exerted the greatest effects of all compounds tested here on formation of continuous tight junction strands
in HUVEC. We further demonstrated that although all compounds induced protein kinase A-dependent expression
of the tight junction proteins claudin-5 and occludin only pCPT-cAMP slightly enhanced paracellular barrier
functions. Moreover, we showed that pCPT-cAMP and 8-Br-cAMP/Na induced expression and membrane
translocation of tricellulin.
Conclusions: pCPT-cAMP and, to a lesser extend, 8-Br-cAMP/Na improved formation of continuous tight junction
strands and decreased paracellular permeability in primary HUVEC. We concluded that under these conditions
HUVEC represent a feasible in vitro model to study formation and disassembly of endothelial tight junctions and to
characterize tight junction-associated proteins
Background
Endothelial cells line the surface of all vascular or lym-
phatic vessels and are connected by intercellular junc-
tions consisting of tight junctions (zonula occludens),
adherens junctions and gap junctions [1]. These junc-
tional complexes control a variety of cellular mechan-
isms like adhesion, paracellular transport or signaling
events [2]. In contrast to most epithelial cells that are
characterized by a highly regulated organization of cellu-
lar junctions interendothelial junctions are far from
being static structures. In fact, both adherens junctions
and tight junctions seem to be intermingled throughout
the cell-cell contact areas [3]. Tight junctions consist of
several transmembrane or membrane-associated pro-
teins including the membrane spanning claudins
(CLDN), occludin (OCLN) and junctional adhesion
molecules (JAM) [3]. Tricellulin (TRIC) represents
another tight junction-associated integral membrane
protein that is localized at tricellular junctions in epithe-
lial cells and is described to regulate paracellular perme-
ability [4,5].
These proteins are connected to the actin cytoskeleton
via adaptor proteins like the zonula occludens (ZO) pro-
teins ZO-1, ZO-2, ZO-3, cingulin, AF6 or 7H6 [6-9].
The main constituents of endothelial adherens junctions
are vascular endothelial cadherin (VE-cadherin) and
catenins that link adherens junctions to the cytoskeleton
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any medium, provided the original work is properly cited.[10]. Recently, a study published by Taddei and co-
workers demonstrated the importance of adherens junc-
tions in controlling proper tight junction formation in
endothelial cells in vitro [11].
A common problem of working with primary
endothelial cells is the rapid loss of many of their
endothelial characteristics as soon as they are cultivated
in vitro. This de-differentiation results from the missing
interaction between endothelial cells and the specific
microenvironment that is necessary for endothelial spe-
cifity [12]. As a consequence, the use of primary
endothelial cells for studying endothelial junctions com-
prises some limitations, e.g. fragmentary assembly of
tight junctions, increased paracellular permeability or
low transelectrical resistance. Therefore, many efforts
have been done to overcome these limitations. For
instance, co-cultures of microvascular endothelial cells
and vascular smooth muscle cells, pericytes or astro-
cytes, or conditioned supernatant of these cells, proved
useful in restoring endothelial barrier properties [13-15].
Also activation of cyclic 3’,5’-adenosine monophosphate
(cAMP)-dependent protein kinase (PKA) by cAMP or
addition of dexamethasone or hydrocortisone have been
shown to successfully improve endothelial junction
architecture [16-19].
A convenient and easy to obtain source for primary
human endothelial cells are umbilical cords, and human
umbilical vein endothelial cells (HUVEC) are widely
used for studying different endothelial cell-related ques-
tions [20-22]. Although HUVEC do not possess the spe-
cific barrier properties found in highly impermeable
microvascular beds like the blood-brain barrier, they are
suitable for studying architecture and formation of
endothelial intercellular junctions. Nevertheless, it is
necessary to induce formation of intercellular junctions
i nH U V E Ca st h e s ec e l l s ,e v e nw h e ng r o w ni nt i g h t
monolayer, display intercellular gaps and discontinuous
junction strands.
The aim of the present study was to compare and
validate different cAMP analogues regarding their effect
on expression of junction-associated proteins and on
formation of continuous tight junction strands as well
as on paracellular permeability in freshly isolated
HUVEC.
Results
Morphology and cellular integrity of HUVEC stimulated
with different cAMP derivates
HUVEC cultivated for several days in EGM-2 medium
formed a monolayer with endothelial-like cobblestone
morphology. Nevertheless, the cells differed in size and
shape and the arrangement of the cells occurred rather
disorganized. Addition of cAMP or its derivates greatly
improved the formation of dense monolayer and the
endothelial cells showed much more uniformity in size
and shape (Figure 1A). Unexpectedly, cAMP and the
bromine derivate 8-Br-cAMP seemed to exhibit cyto-
toxic side effects as HUVEC exposed to these com-
pounds for 72 h showed a dense ring of vacuoles
around the nucleus and the cell borders seemed to van-
ish. In contrast, HUVEC treated with pCPT-cAMP or 8-
Br-cAMP/Na for 72 h showed no sign of cytotoxicity
and the cell borders were clearly visible in phase con-
trast microscopy (Figure 1A). In order to analyze the
effect of the different cAMP derivates on cellular home-
ostasis we determined the ratio of viable and dead cells
by measuring the release of a cell membrane-imperme-
able protease. HUVEC treated with a combination of
tumor necrosis factor-alpha (TNF-a, 3 nmol/l) and
camptothecin (CPT, 0.15 μmol/l) served as positive con-
trol. All four cAMP derivates showed a higher ratio of
dead cells compared to untreated cells in the first 24 h.
Nevertheless, this potential cytotoxic effect disappeared
in the next 24 h and after 72 h the ratio of dead cells
was comparable to or, in the case of pCPT-cAMP, even
below that of untreated cells (Figure 1B). Concordant
with these results intracellular concentrations of ATP as
indicator for metabolic activity slightly decreased in the
first 24 h upon exposure to the cAMP derivates com-
pared to untreated cells. After 72 h pCPT-cAMP-treated
and untreated cells showed equivalent levels of intracel-
lular ATP whereas the other three derivates induced a
slight decrease of cellular ATP (Figure 1C). We also
determined activation of caspases 3 and 7 as indicator
for induction of apoptosis. Activation of caspases 3/7
did not significantly differ upon treatment with the
cAMP derivates compared to untreated cells whereas
stimulation with TNF-a and CPT strongly increased the
signals for active caspases 3/7 (Figure 1D).
Cellular localization and distribution of junction-
associated proteins
We next performed immunostainings for the adherens
junction protein VE-cadherin and the tight junction
associated proteins ZO-1, OCLN, Jam-A and CLDN5 to
analyze their cellular distribution in response to cAMP
or its derivates. HUVEC cultivated for 24 h in EGM-2
medium without any additional supplementation with
cAMP or its derivates showed discontinuous VE-cad-
herin-positive strands with intercellular gaps. In the next
48 h these intercellular gaps disappeared but the discon-
tinuity of the VE-cadherin-positive strands remained
(additional file 1). Likewise, the staining pattern for the
tight junction-associated proteins ZO-1, OCLN, CLDN5
and Jam-A revealed discontinuous or intermittent junc-
tion strands suggesting that EGM-2 medium alone is
not sufficient to induce proper assembly of continuous
tight junction strands (Figure 2 and 3). In contrast,
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continuous junction strands as shown by immunostain-
ings for ZO-1, OCLN, CLDN5 and Jam-A (Figure 2).
Nonetheless, we observed that the junction strands
seemed to disintegrate again after stimulation periods
for 72 h (Figure 3). Concordant with these results,
HUVEC stimulated with 8-Br-cAMP showed continuous
assembly of tight junction strands in the first 24 h but
after 72 h the junction strands disassembled again. The
same temporal pattern could be observed after stimula-
tion with 8-Br-cAMP/Na. Although this compound
obviously showed no cytotoxicity the most notably effect
on inducing continuous adherens and tight junction-
strands occurred in the first 24 h whereas in the next 48
h the junctions started to separate again (Figure 2 and
3). These results suggest that 8-Br-cAMP/Na is prefer-
entially applicable for short term experiments. pCPT-
cAMP, on the other hand, showed its greatest effects on
HUVEC after incubation for 72 h (Figure 3). After this
time period immunostainings for ZO-1, OCLN, Jam-A
or CLDN5 revealed continuous tight junction strands.
The cells displayed a regular shape and there was no
sign of cytotoxicity. The appropriate stainings of ZO-1,
OCLN, Jam-A and CLDN5 after stimulation with cAMP
or its derivates for 48 h are shown in additional file 2.
To further analyze the effect of pCPT-cAMP on survival
and cytotoxicity we cultivated the cells for more than
10 days with pCPT-cAMP. Even after this time period
the cells looked healthy and still grew in a tight mono-
layer (data not shown).
cAMP derivates influence formation and dissociation of
tight junctions in a calcium switch model
We then performed calcium switch experiments to ana-
lyze whether the different cAMP derivates modulate
the responsiveness of HUVEC to altered calcium
Figure 1 Morphology and cellular integrity of HUVEC treated with different cAMP derivates. (A) Stimulation of HUVEC for 72 h with cAMP
or 8-Br-cAMP induced a regular monolayer but led to extensive vacuolization (white arrows) that may represent signs of cytotoxicity (a,b). Cells
stimulated with 8-Br-cAMP/Na or pCPT-cAMP grew in a dense monolayer with regularly arranged cells and visible cell borders (c,d) without any
signs of cytotoxicity. Shown are representative micrographs of at least three experiments with cells derived from different donors. (B) All four
cAMP derivates induced enhanced cellular cytotoxicity in the first 24 h whereas after 72 h the ratio of dead and viable cells is comparable or, for
pCPT-cAMP, even below that of untreated cells. TNF-a/CPT treated HUVEC served as positive control. (n = 3) (C) Exposure to cAMP, 8-Br-cAMP or
8-Br-cAMP/Na induced a slight reduction in intracellular ATP level over the whole time period. Treatment with pCPT-cAMP resulted in a partial
decrease of cellular ATP concentrations after 24 h but showed no differences to untreated cells after 72 h. (n = 3) (D) All four cAMP derivates
induced a slight decrease in caspase3/7 activity after 24 h. After 48 h and 72 h level of activated caspases are comparable to those of untreated
cells (n = 4). Scale bar represent 25 μm.
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Page 3 of 14Figure 2 Short-term effect of cAMP and its derivates on formation of tight junctions. Cells were stimulated for 24 h with different cAMP
derivates, stained for tight junction-associated proteins ZO-1, OCLN, CLDN5 and Jam-A and analyzed by confocal laser microscopy. The nucleus
was counterstained with DAPI. Depicted are representative micrographs of at least three independent experiments using HUVEC from different
donors. Scale bar represents 25 μm.
Figure 3 Long-term effect of cAMP and its derivates on formation of tight junctions. HUVEC were stimulated for 72 h with the different
cAMP derivates, stained for tight junction-associated proteins ZO-1, OCLN, CLDN5 and Jam-A and analyzed by confocal laser microscopy. The
nucleus was counterstained with DAPI. Shown are representative micrographs of at least three independent experiments using HUVEC from
different donors. Scale bar represents 25 μm.
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Page 4 of 14concentrations in the culture medium. In a first set of
experiments HUVEC were stimulated with the different
cAMP derivates for 24 h before they were cultivated
under low calcium for 2 h. Addition of EDTA (3 mmol/
l) to the normal culture medium or cultivation in cal-
cium-free buffer resulted in the specific loss of tricellular
junctions in HUVEC exposed to pCPT-cAMP or 8-Br-
cAMP/Na. Subsequent reconstitution of the normal cal-
cium concentration restored the continuous junction
strands. Interestingly, removal of calcium induced a
much greater effect on opening of tight junction in cells
exposed to cAMP or 8-Br-cAMP. In these cells not only
the tricellular junctions were lost but also bicellular
junctions started to disintegrate. Restoring the original
calcium concentration could reestablish continuous
junction strands only in the 8-Br-cAMP-treated cells
whereas cAMP-treated HUVEC failed to form continu-
ous ZO-1 or CLDN5-positive strands. In untreated cells
calcium depletion increased the discontinuity of junction
strands, and restoring the original calcium concentration
did not seem to have any beneficial effect on reorganiza-
tion of cell-cell junctions (Figure 4). In a second
approach the cells were treated with the cAMP derivates
for 72 h before removal of calcium. Similar to the first
experiments HUVEC pretreated with pCPT-cAMP or
8-Br-cAMP showed loss of tricellular junctions at low
calcium concentrations but reestablished continuous
junction strands after restoring the original calcium con-
centration. 8-Br-cAMP/Na and cAMP treated cells
showed enhanced loss of tri- and bicellular junctions
and failed to reestablish continuous tight junctions after
restoring calcium concentration (data not shown).
Expression of tight junction-associated proteins
We also tested the different compounds for their impact
on gene expression and protein synthesis in HUVEC.
Transcript amounts of ZO-1, Jam-A and VE-cadherin
did not change significantly in treated cells compared to
untreated controls (additional file 3). In contrast, cAMP
and its derivates induced a significant increase in
CLDN5 transcript amounts after 24 h. CLDN5 mRNA
level in cells treated with pCPT-cAMP or 8-Br-cAMP/
Na remained elevated whereas cAMP or 8-Br-cAMP in
turn led to a decline in transcript expression after 48 h.
CLDN5 transcript level in untreated cells remained
almost unchanged over the whole time (Figure 5A).
mRNA expression of OCLN was strongly enhanced
after 24 h following treatment with 8-Br-cAMP/Na and
pCPT-cAMP whereas untreated cells showed increased
OCLN expression with a temporal delay of 24 h. Never-
theless, after 72 h the mRNA level did not differ signifi-
cantly within these three groups. In contrast,
Figure 4 cAMP derivates influence formation and dissociation of tight junctions in a calcium switch model. HUVEC were treated for 24 h
with cAMP or its derivates. Calcium was either chelated by addition of 3 mM EDTA or medium was exchanged with calcium-free PBS. After 2 h
cells were washed and cultivated for additional 4 h in EGM medium supplemented with the appropriate cAMP derivates. Cells were fixed and
stained for CLDN5 (red) and ZO-1 (green). White arrows indicate specific loss of tricellular junctions. Shown are representative micrographs of
three independent experiments. Scale bar represents 25 μm.
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Page 5 of 14Figure 5 cAMP and its analogues modulate mRNA and protein expression. HUVEC were stimulated with cAMP or its derivates for up to
72 h and changes in transcript amount and protein expression were determined by real-time qPCR and western blotting. (A) real-time qPCR
revealed a strong induction of CLDN5 and OCLN mRNA synthesis after stimulation with pCPT-cAMP and 8-Br-cAMP/Na over the whole time
period whereas cAMP and 8-Br-cAMP induced only a temporal increase in CLDN5 transcript amount and obviously had no effect on OCLN
mRNA expression. Untreated cells showed no differences in CLDN5 expression but a significant increase in OCLN transcript amount after 48 h.
(n = 3). (B) Shown are western blots of HUVEC treated for 24 to 72 h with different cAMP derivates. Protein lysates of HUVEC were separated by
electrophoresis, blotted and OCLN and CLDN5 were detected with specific antibodies. Protein amounts of tubulin served as loading controls.
(n = 5); (*p < 0.01 compared to untreated controls).
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Page 6 of 14stimulation with cAMP and 8-Br-cAMP did not induce
any significant increase in OCLN transcript amount
(Figure 5A). We then performed western blots to ana-
lyze whether the changes in gene expression had any
influence on protein amounts. All cAMP derivates
induced an increase in CLDN5 protein amount with
pCPT-cAMP and 8-Br-cAMP/Na leading to the highest
increase after 72 h. These results are consistent with the
data obtained by real-time qPCR. Accordingly, HUVEC
exposed to pCPT-cAMP and 8-Br-cAMP/Na displayed
the highest level of OCLN protein (Figure 5B).
Effects of cAMP derivates on tight junctions are partly
dependent on PKA
As evidence exists that cAMP signals through PKA-
dependent and PKA-independent mechanisms we ana-
l y z e dw h e t h e rt h eo b s e r v e de f f e c t so ft h ec A M P
derivates were modulated by PKA. HUVEC were pre-
treated with the PKA-specific inhibitor H-89 (10 μmol/
l), subsequently exposed to the different cAMP derivates
f o ru pt o7 2ha n dm R N Aa n dp r o t e i na m o u n to f
OCLN and CLDN5 were measured by real-time qPCR
and western blotting, respectively. Inhibition of PKA by
H-89 clearly prevented the increase in transcript and
protein synthesis induced by cAMP or its derivates
(additional file 4). We then performed immunostaining
f o rZ O - 1a n dC L D N 5i nH U V E Cp r e t r e a t e dw i t hH - 8 9
and exposed to the different cAMP derivates for 24 and
72 h. As could be seen in Figure 6A, stimulation with
the PKA inhibitor alone seemed to induce swelling of
the cells. This effect might be explained by increased
influx of water into the cells. Although stimulation with
cAMP derivates improved the formation of continuous
ZO-1 and CLDN5-positive strands the shape of the cells
differed markedly from those cells who did not receive
the inhibitor. However, treatment with cAMP and
pCPT-cAMP for 24 h seemed to decelerate the rate of
cell swelling compared to the two bromine compounds.
After 72 h H-89-treated cells lost their junctional integ-
rity, intercellular gaps occurred and CLDN5 seemed to
accumulate in the cytoplasm. Also cells treated with 8-
Br-cAMP/Na showed increased cytosolic staining of
CLDN5. However, HUVEC exposed to cAMP, pCPT-
cAMP and 8-Br-cAMP still displayed continuous junc-
tion structures suggesting that expression but not neces-
sarily membrane localization of tight junction proteins is
mediated by PKA (Figure 6B).
Effect of cAMP derivates on expression of TRIC
We then analyzed expression and distribution of the
recently discovered tight junction-associated protein
TRIC in response to the four cAMP derivates. Real-time
qPCR revealed that in HUVEC TRIC is expressed at
very low level compared to expression of other
junction-associated proteins like Jam-A, OCLN or
CLDN5. Nevertheless, after 48 h mRNA amounts of
TRIC were clearly elevated in cells stimulated with
pCPT-cAMP, 8-Br-cAMP/Na or cAMP compared to
untreated cells. After 72 h mRNA level of TRIC
increased even further compared to untreated controls.
8-Br-cAMP, on the other hand, led to a decrease in
TRIC mRNA level over the whole time period
(Figure 7A).
We then performed immunostainings for TRIC. Con-
cordant with the low expression level immunostainings
for TRIC are almost not visible in untreated HUVEC
(data not shown). Stimulation with pCPT-cAMP and 8-
Br-cAMP/Na for 24 h inducedav e r yf a i n tm e m b r a n e
staining of TRIC whereas after 72 h TRIC localization is
clearly visible along bicellular junctions (Figure 7B).
However, we were not able to see TRIC membrane
staining in HUVEC treated with cAMP although this
compound induced an increase in TRIC mRNA expres-
sion. Of interest, different to epithelial cells TRIC could
not be localized at tricellular junctions in HUVEC.
Changes in paracellular permeability
To analyze whether the different cAMP analogues
improved barrier properties in HUVEC we measured
paracellular tracer flux using the small molecular weight
markers Lucifer yellow (LY) and sodium-FITC (Na-F) or
FITC-labeled dextrans with molecular masses of 10 to
70 kDa. All four cAMP derivates tested here led to a
decrease in paracellular permeability towards Na-F after
72 h. In contrast, only pCPT-cAMP showed a beneficial
effect towards flux of LY and the different FITC-dex-
trans at all time points (Figure 8A). In a second
approach the cells were pretreated with recombinant
human thrombin (2 U/mL) to test the effect of the
cAMP derivates in response to a known opener of tight
junctions. Interestingly, all four compounds reduced the
thrombin-induced increase in permeability towards the
70 kDa dextran significantly as compared to cells that
did not receive cAMP. Regarding flux of the 20 kDa
dextran all but 8-Br-cAMP revealed beneficial effects on
thrombin-induced permeability. In contrast, only pCPT-
cAMP significantly reduced paracellular flux of the
small molecular weight marker LY (Figure 8B).
Discussion
T h ea i mo ft h ep r e s e n ts t u d yw a st oe v a l u a t ew h e t h e r
primary macrovascular endothelial cells isolated from
human umbilical cords prove useful as a cell culture
model to study tight junction assembly. The decision to
choose HUVEC for these assays was based on the fact
that umbilical cords are easy to obtain and the subse-
quent isolation of the endothelial cells out of the vein is
well described and does not require specific technical
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Page 7 of 14Figure 6 cAMP-induced formation of junction strands is independent of PKA. HUVEC were pretreated with H-89 and exposed to the
different cAMP derivates for (A) 24 h or (B) 72 h. Cells were fixed and double stainings for ZO-1 (green) and CLDN5 (red) were performed.
Shown are representative micrographs of three independent experiments. Scale bar represents 25 μm.
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Page 8 of 14skills [21,23]. We also decided to concentrate on human
cells as a broad variety of appropriate antibodies direc-
ted against human tight and adherens junction-asso-
ciated proteins are available.
Although endothelial cells apparently form dense mono-
layer in vitro microscopic analysis revealed intercellular
gaps and clefts as well as discontinuous junction strands
[24] demonstrating that single monocultures of endothelial
cells are not sufficient to induce proper cellular junction
formation. Therefore, many approaches were undertaken
to overcome these limitations by co-cultivating endothelial
cells with “helper cells” like astrocytes or pericytes or with
their appropriate conditioned cell culture medium. Under
these conditions cerebral microvascular endothelial cells
succeeded in building blood-brain barrier like monolayer
with enhanced transelectrical resistance and decreased
paracellular permeability [15,25-27].
Another approach takes advantage of the junction-pro-
tecting effect of the second messenger cAMP. Beneath its
ability to modulate PKA activity cAMP directly influences
Epac, a guanine nucleotide exchange factor for Rap1 that
modulates actin reorganization and distribution of adhe-
rens and tight junction-associated proteins [28,29].
We here focused on the cAMP-approach and
described the effects of different cAMP analogues on
formation of cellular junctions and changes in paracellu-
lar permeability in HUVEC. Although the effect of
cAMP on assembly of tight junctions in endothelial cells
is well known a characterization of the cellular and
molecular events that are modulated by different cAMP
derivates is necessary as endothelial cells from macro-
or microvascular beds may differ in their response to
cAMP. Moreover, evidence exists that different chemi-
cally modified cAMP analogues modulate specific cellu-
lar responses. Recently, a study by Sand and colleagues
demonstrated that 8-CPT-conjugated but not bromine-
conjugated cAMP analogues act as competitive throm-
boxane receptor antagonists [30].
We here demonstrated that, although all cAMP deri-
vates improved formation of continuous junction strands
in HUVEC, they differ regarding their cell compatibility
and kinetics of junction assembly. cAMP, 8-Br-cAMP
and its sodium salt 8-Br-cAMP/Na induced formation of
continuous tight junction strands as soon as 24 h after
addition. Nevertheless, longer incubation periods led to a
disassembly of the junction strands suggesting that these
compounds proved useful for solely short-termed experi-
ments. Moreover, they did not show any significant effect
on improving paracellular permeability of HUVEC
monolayer and, more importantly, cAMP and 8-Br-
cAMP seemed to induce extensive vacuolization when
exposed for longer time periods. pCPT-cAMP, on the
other hand, displayed its best effects on HUVEC when
added for longer time periods (≥72h) and generated the
most robust phenotype as shown by calcium switch
experiments. Moreover, pCPT-cAMP is the only com-
pound that actually induced an improvement in barrier
properties. Nevertheless, all four compounds reduced
thrombin-induced increases in paracellular permeability
to a certain degree and partly diminished breakdown of
junctions in response to calcium depletion. These results
suggest that cAMP and its derivates exhibit rather
Figure 7 Effect of cAMP derivates on expression and
localization of TRIC. (A) pCPT-cAMP, 8-Br-cAMP/Na and cAMP
induced increased expression of TRIC mRNA as determined by real-
time qPCR. Expression data were normalized to expression of HPRT-
1 (n = 3). (B) pCPT-cAMP and 8-Br-cAMP/Na induced a faint
membrane translocation of TRIC after 24 h. After 72 h 8-Br-cAMP/
Na-stimulated cells showed rather strong membrane localization
of TRIC whereas pCPT-cAMP led to only moderate TRIC staining
(n = 4). The nucleus was counterstained with DAPI. Scale bar
represents 25 μm.
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Page 9 of 14Figure 8 Paracellular tracer flux assay. (A) changes in permeability to LY, Na-F or FITC-dextrans with molecular masses of 10 kDa, 20 kDa and
70 kDa were determined after stimulation with cAMP or its derivates for 24 to 72 h. (B) Endothelial monolayer were stimulated with the
different cAMP derivates for 72 h. Paracellular permeability towards LY, FD20 and FD70 was determined after pretreatment of the cells with
thrombin (2 U/mL). Shown are results from three independent experiments with HUVEC derived from different donors. (*p < 0.05 compared to
untreated controls).
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improving existing barrier properties.
For us, it was interesting to note that the compounds
tested here had different effects on transcript expression
of tight junction-associated proteins in HUVEC. All four
cAMP derivates induced enhanced synthesis of CLDN5
mRNA after 24 h but only in pCPT-cAMP and 8-Br-
cAMP/Na-treated cells mRNA level of CLDN5 remained
elevated in the next 48 h. CLDN5 is one of the main
endothelial tight junction proteins and its expression
correlates with formation of tight junctions and
endothelial barrier properties [31-33]. On the other
hand, substances known to disrupt endothelial barrier
properties down-regulate CLDN5 transcript amounts
[34]. Concordantly, the expression profiles of CLDN5
mRNA correlated quite well with the assembly of proper
tight junction strands in HUVEC treated with the differ-
ent cAMP derivates. Expression of OCLN mRNA
followed a slightly different pattern. Although pCPT-
cAMP and 8-Br-cAMP/Na showed the greatest effect on
induction of OCLN after 24 h at the end of the experi-
ment mRNA level did not differ compared to untreated
cells. Surprisingly, the remaining two cAMP derivates
did not induce any significant changes in OCLN expres-
sion. We therefore performed western blots for CLDN5
and OCLN. Whereas the protein and mRNA data for
CLDN were consistent expression of OCLN was
increased after stimulation with all four cAMP derivates.
This discrepancy might be explained by the fact that
changes in mRNA expression do not necessarily induce
altered protein synthesis and that in case of doubt the
protein analysis provided the most reliable data.
It is well known that cAMP exerts both PKA-depen-
dent and -independent effects. In HUVEC cAMP-
induced expression of OCLN and CLDN5 is controlled
by PKA whereas membrane translocation and formation
of continuous strands seemed to be independent of
PKA at least for pCPT-cAMP, cAMP and 8-Br-cAMP.
Interestingly, these findings are in opposite to a study
by Ishizaki et al. who showed that induction of CLDN5
by pCPT-cAMP in brain microvascular endothelial cells
is independent of PKA [33]. This discrepancy may be
explained by the different sources of the endothelial
cells; we used human macrovascular cells whereas the
group of Ishizaki worked on microvascular cells isolated
from porcine brain capillaries.
The intention of this study was to evaluate whether
HUVEC proved to be suitable for studying endothelial
tight junction formation. These primary endothelial cells
express most if not all of the known endothelial adhe-
rens and tight junction-associated proteins and form
proper junction strands when cultured under appropri-
ate conditions. Nevertheless, they definitely miss some
of the typical vascular endothelial characteristics like
increased transelectrical resistance or highly imperme-
able paracellular barriers found in other endothelial cell
culture models established to study e.g. blood-brain bar-
rier properties in vitro [35,36]. Certainly, these different
properties of the cells are due to the specific vascular
beds they derived from. Whereas most of the culture
models used for permeability and drug transport studies
utilizes cerebral microvascular endothelial cells we
worked with macrovascular venous endothelial cells
from the umbilical cord. Accordingly, HUVEC are defi-
nitely not an adequate model to study blood-brain bar-
rier-related topics. But on the other hand, umbilical
cords are easy to obtain, and isolation of HUVEC does
not require highly specific technical skills and is not as
time-consuming as, for example, isolation of microvas-
cular endothelial cells. Therefore, they represent a suita-
ble culture model for studying formation or disassembly
of endothelial intercellular junctions and the signaling
pathways that are linked to this process.
Conclusions
In summary, we demonstrated that for short-term
experiments 8-Br-cAMP/Na and for long-term studies
pCPT-cAMP have shown to be useful for formation of
dense endothelial monolayer and induction of continu-
ous tight junction strands in HUVEC. We concluded
that HUVEC proved useful for studying formation and
disassembly of endothelial junction architecture or char-
acterization of junction-associated proteins. Neverthe-
less, their use for studying functional parameters e.g.
paracellular transport or permeability seemed to be
restricted under the conditions tested here.
Methods
Cells
HUVEC were isolated from umbilical cords as described
earlier [37] with the only modification that collagenase II
(Biochrom, Berlin, Germany) was used instead of chymo-
trypsin. Cells were maintained in EBM-2 basal medium
supplemented with the EGM-2 SingleQuot kit containing
growth factors, gentamycin, amphotericin-B and 2% fetal
bovine serum (Lonza, Vervier, Belgium). Contaminating
fibroblasts were removed using CD90-coated paramag-
netic beads (Invitrogen, Karlsruhe, Germany). For all
experiments HUVEC were used up to passage three. The
use of HUVEC was approved by the Hannover Medical
School Ethics Committee and conducted in accordance
with the Declaration of Helsinki. Written informed con-
sent was obtained from all patients.
Stimulation of HUVEC with cAMP or cAMP-derivates
HUVEC were seeded at a density of 10
5 cells/ml and culti-
vated for 3 to 5 h to allow adherence of cells. Non-adhered
cells were removed and cells were stimulated with cAMP
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0.25 mg/ml (Sigma-Aldrich, Munich, Germany) for the
indicated time intervals. Medium was changed every 24 h
and HUVEC were processed according to the appropriate
downstream applications. For inhibition of PKA HUVEC
were pretreated for 30 minutes with the specific inhibitor
H-89 (Cell Signaling/NEBiolabs, Frankfurt, Germany) at a
final concentration of 10 μmol/l.
Determination of cellular cytotoxicity or apoptosis
Cellular cytotoxicity and metabolic activity of HUVEC due
to the different cAMP derivates was determined using the
CytoTox-Glo Cytotoxicity and the CellTiter-Glo Lumines-
cent Cell Viability assay (Promega, Mannheim, Germany).
Activation of caspases 3 and 7 was measured using the
Caspase-Glo 3/7 assay (Promega). Assays were performed
according to the manufacturer’s instruction.
Calcium switch experiments
HUVEC were normally cultivated in EGM medium that
contain several sources of calcium like D-calcium pan-
tothenate, folinic acid calcium salt or calcium chloride
dehydrate. To generate a calcium-free environment the
cells were cultivated for 2 h in EGM medium in the pre-
sence of EDTA (3 μM) to chelate the free calcium or in
PBS without any calcium but supplemented with all
growth factors contained in the Lonza single quots.
After 2 h medium was changed to normal EGM med-
ium with the appropriate cAMP derivates and cells were
cultivated for another 4 h before they were fixed.
RNA extraction and real-time quantitative PCR (qPCR)
Cells were lysed and RNA was extracted using RNeasy
mini columns with an on-column DNase-digest (Qiagen,
Hilden, Germany). Concentration of RNA was determined
and 2 μg of total RNA was reverse transcribed using a
MMLV RNase H minus point mutant reverse transcriptase
(Promega). Real-time qPCR was carried out on a LightCy-
cer480-II System (Roche Diagnostics, Penzberg, Germany)
using FastStart Polymerase (Roche Diagnostics) and SYBR-
Green I (Invitrogen). Gene-specific oligonucleotides for
OCLN, CLDN5, Jam-A, ZO-1 and VE-cadherin were
obtained from Qiagen (QuantiTect Primer Assay) with the
corresponding ordering numbers listed in Table 2. PCR
results were normalized to the expression of hypoxanthine
guanine phosphoribosyltransferse 1 (HPRT-1) and analyzed
using qGene software [38]. The sequences of the HPRT-1
oligonucleotides were TGACACTGGCAAAACAATGCA
and GGTCCTTT TCACCAGCAAGCT. Each experiment
was repeated at least three times with HUVEC derived
from different donors.
Western blot
Cells were lysed in ice-cold 1 × lysis buffer (NEBiolabs,
Frankfurt, Germany) containing protease and phospha-
tase inhibitor cocktail tablets (Roche Diagnostics). Pro-
tein content of the samples was determined using the
BCA protein assay kit (Thermo Fisher Scientific, Bonn,
Germany). 50 μg of whole cell lysates was separated by
SDS PAGE electrophoresis and blotted on a PVDF
nylon membrane. Filters were incubated with the appro-
priate primary antibody followed by incubation with a
HRP-conjugated secondary antibody. The bands were
visualized by Western Lighting chemiluminiscence
reagent (Perkin Elmer, Rodgau, Germany) and quanti-
fied by densitometry using a CCD camera and Quantity
One software (Biorad Laboratories, Munich, Germany).
Immunocytochemistry
Cells were grown on collagen-coated glass cover slips
and fixed in ice-cold acetone for 15 minutes at -20°C
followed by permeabilization with ice-cold methanol for
20 min at -20°C. After washing with PBS the cells were
blocked in normal donkey serum, incubated with the
primary antibody for one hour followed by incubation
with the appropriate secondary antibody coupled to
ALEXA-488 or ALEXA-546 (Invitrogen) for an addi-
tional hour. DNA was counterstained with DAPI (Sigma
Aldrich) and confocal images were taken using a Leica
DM IRB microscope with a TCS SP3 AOBS scan head
equipped with argon and krypton laser beams. Micro-
graphs were obtained using a HCX PL APO 63 × 1.4
numerical aperture objective. Antibodies used in this
study were a murine monoclonal anti-VE-cadherin
Table 1 cAMP derivates used in this study and their final
working concentration
Substances Abbr. Concentration
cyclic 3’,5’-adenosine
monophosphate
(cAMP) 0.25 mg/ml
8-bromoadenosine 3’5’-cyclic
monophosphate
(8-Br-cAMP) 0.25 mg/ml
8-bromoadenosine 3’,5’-cyclic
monophosphate sodium salt
(8-Br-cAMP/Na) 0.25 mg/ml
8-(4-chlorophenylthio)adenosine
3’,5’-cyclic monophosphate
sodium salt
(pCPT-cAMP) 0.25 mg/ml
Table 2 Ordering information of the QuantiTect primer
assays
Oligonucleotides Ordering numbers (Qiagen)
Jam-A QT00083972
CLDN5 QT01681232
OCLN QT00081844
TRIC QT01031919
VE-cadherin QT00013244
ZO-1 QT00077308
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Page 12 of 14(clone 55-7H1 from BD Pharmingen, Heidelberg, Ger-
many; working concentration 1 ng/μl), a murine mono-
clonal anti-ZO-1 antibody (clone 1/ZO-1 from BD
Pharmingen, working concentration 2.5 ng/μl), a murine
monoclonal anti-OCLN antibody (clone 3F10 from Invi-
trogen, working concentration 5 ng/μL), a polyclonal
goat anti-Jam-A antibody (R&D Systems, Wiesbaden,
Germany, working concentration 1 ng/μl), a polyclonal
anti-TRIC antibody (Invitrogen) and a rabbit anti-
CLDN5 antibody (Santa Cruz Biotechniques, Heidelberg,
Germany, working concentration 2 ng/μl).
Paracellular tracer flux assay
For determination of paracellular permeability HUVEC
were seeded into the upper compartment of transwell
devices with a pore size of 0.4 μm and cultivated for two
days to reach confluence. After stimulation for 24 to 72 h
with cAMP or its derivates the low molecular weight mar-
kers Lucifer yellow (LY, 457 Da, 20 μmol/L) and sodium
fluorescein (Na-F, 10 μg/mL) or fluorescein (FITC)-
coupled dextrans with the molecular masses of 10 kDa, 20
kDa or 70 kDa (of 200 μg/ml) were added to the upper
compartment (Sigma-Alrich). In some experiments cells
were pretreated with thrombin (2 U/mL, Merck, Darm-
stadt, Germany). After 30 minutes the concentrations of
FITC-labeled dextrans in the lower compartment were
measured using an ELISA reader equipped for fluores-
cence measurement (Tecan, Crailsheim, Germany).
Statistical analysis
Results were expressed as the mean ± SD of at least
three independent experiments with cells derived from
different donors. Statistical significance was calculated
using Mann-Whitney-U test.
Additional material
Additional file 1: Immunostainings of VE-cadherin. HUVEC were
stimulated with cAMP or different cAMP derivates for 24 to 72 h and
stained for VE-cadherin. The nucleus was counterstained with DAPI.
Shown are representative confocal images of at least three independent
experiments with HUVEC derived from different donors. Scale bar
represents 25 μm.
Additional file 2: Immunostainings of tight junction marker after
48 h stimulation with cAMP derivates. Shown are representative
micrographs of immunostainings for ZO-1, OCLN, Jam-A and CLDN5 in
HUVEC that were stimulated with cAMP or its derivates for 48 h. The
nucleus was counterstained with DAPI. Scale bar represents 25 μm.
Additional file 3: mRNA expression data of junction-associated
proteins. HUVEC were stimulated for 24 to 72 h with cAMP or its
derivates. RNA was extracted, reverse transcribed and expression of VE-
cadherin, ZO-1 and Jam-A was determined by real-time qPCR. Expression
data were normalized to relative transcript amounts of HPRT-1 (n = 3).
Additional file 4: cAMP-induced expression of CLDN5 and OCLN is
mediated by PKA. (A) HUVEC were pretreated with H-89 for 30 minutes
and stimulated with cAMP or its derivates for up to 72 h. mRNA
expression of OCLN and CLDN5 were determined by real-time qPCR and
normalized to expression of HPRT-1 (n = 3). (B) Shown are representative
western blot images of HUVEC pretreated with H-89 for 30 minutes and
stimulated with cAMP derivates for up to 72 h. Protein amounts of
tubulin served as loading control (n = 2).
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